| Utility: Methods for the regulation of matrix metalloproteinase expression Filling date: 8 Sep 2025 Issue date: 8 Mar 2022 | 2 Dec 2019 | 8 Mar 2022 |
| Utility: MITOCHONDRIA-TARGETING PEPTIDES Filling date: 8 Sep 2025 Issue date: 10 Feb 2022 | 19 Nov 2019 | 10 Feb 2022 |
| Utility: METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF BARTH SYNDROME Filling date: 8 Sep 2025 Issue date: 30 Dec 2021 | 9 Jul 2021 | 30 Dec 2021 |
| Utility: METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING DOMINANT OPTIC ATROPHY Filling date: 8 Sep 2025 Issue date: 30 Dec 2021 | 16 Apr 2021 | 30 Dec 2021 |
| Utility: COMPOSITIONS AND METHODS FOR THE TREATMENT OF TRAUMATIC OPTIC NEUROPATHY Filling date: 8 Sep 2025 Issue date: 28 Oct 2021 | 15 Jul 2019 | 28 Oct 2021 |
| Utility: COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA Filling date: 8 Sep 2025 Issue date: 14 Oct 2021 | 2 Apr 2021 | 14 Oct 2021 |
| Utility: Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof Filling date: 8 Sep 2025 Issue date: 12 Oct 2021 | 17 Jan 2020 | 12 Oct 2021 |
| Utility: CRYSTALLINE SALT FORMS OF BOC-D-ARG-DMT-LYS-(BOC)-PHE-NH2 Filling date: 8 Sep 2025 Issue date: 23 Sep 2021 | 8 Apr 2021 | 23 Sep 2021 |
| Utility: Methods and compositions for the prevention or treatment of Barth Syndrome Filling date: 8 Sep 2025 Issue date: 10 Aug 2021 | 15 Jul 2020 | 10 Aug 2021 |
| Utility: Methods and compositions for the prevention or treatment of Barth Syndrome Filling date: 8 Sep 2025 Issue date: 10 Aug 2021 | 19 Jun 2017 | 10 Aug 2021 |
| Utility: METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA Filling date: 8 Sep 2025 Issue date: 22 Jul 2021 | 30 Oct 2020 | 22 Jul 2021 |
| Utility: COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA Filling date: 8 Sep 2025 Issue date: 8 Jul 2021 | 2 Oct 2020 | 8 Jul 2021 |
| Utility: Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH.sub.2 Filling date: 8 Sep 2025 Issue date: 15 Jun 2021 | 4 Apr 2018 | 15 Jun 2021 |
| Utility: METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS Filling date: 8 Sep 2025 Issue date: 27 May 2021 | 2 Jul 2020 | 27 May 2021 |
| Utility: AROMATIC-CATIONIC PEPTIDES AND USES OF SAME Filling date: 8 Sep 2025 Issue date: 6 May 2021 | 17 Jun 2020 | 6 May 2021 |
| Utility: Crystalline dipeptides useful in the synthesis of elamipretide Filling date: 8 Sep 2025 Issue date: 13 Apr 2021 | 28 Mar 2019 | 13 Apr 2021 |
| Utility: N-carboxyanhydride-based-scale synthesis of elamipretide Filling date: 8 Sep 2025 Issue date: 30 Mar 2021 | 9 Aug 2017 | 30 Mar 2021 |
| Utility: CRYSTALLINE BIS- AND TRIS-HYDROCHLORIDE SALT OF ELAMIPRETIDE Filling date: 8 Sep 2025 Issue date: 4 Mar 2021 | 4 May 2020 | 4 Mar 2021 |
| Utility: CRYSTALLINE SALT FORMS Filling date: 8 Sep 2025 Issue date: 18 Feb 2021 | 4 May 2020 | 18 Feb 2021 |
| Utility: METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE Filling date: 8 Sep 2025 Issue date: 18 Feb 2021 | 24 Mar 2020 | 18 Feb 2021 |
| Utility: METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY Filling date: 8 Sep 2025 Issue date: 11 Feb 2021 | 17 Mar 2020 | 11 Feb 2021 |
| Utility: AROMATIC-CATIONIC PEPTIDES AND USES OF SAME Filling date: 8 Sep 2025 Issue date: 11 Feb 2021 | 13 Mar 2020 | 11 Feb 2021 |
| Utility: METHODS OF IDENTIFYING AND MONITORING MITOCHONDRIAL DYSFUNCTION USING MONOCYTE SCREENING Filling date: 8 Sep 2025 Issue date: 28 Jan 2021 | 10 Apr 2020 | 28 Jan 2021 |
| Utility: METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY Filling date: 8 Sep 2025 Issue date: 28 Jan 2021 | 28 Feb 2020 | 28 Jan 2021 |
| Utility: METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE Filling date: 8 Sep 2025 Issue date: 31 Dec 2020 | 15 Jul 2020 | 31 Dec 2020 |
| Utility: METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT NEUROPATHY Filling date: 8 Sep 2025 Issue date: 24 Dec 2020 | 7 Apr 2020 | 24 Dec 2020 |
| Utility: METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DISEASE Filling date: 8 Sep 2025 Issue date: 3 Dec 2020 | 17 Aug 2020 | 3 Dec 2020 |
| Utility: CRYSTALLINE SALT FORMS OF BOC-D-ARG-DMT-LYS-(BOC)-PHE-NH2 Filling date: 8 Sep 2025 Issue date: 26 Nov 2020 | 4 Apr 2018 | 26 Nov 2020 |
| Utility: METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH Filling date: 8 Sep 2025 Issue date: 19 Nov 2020 | 20 Dec 2019 | 19 Nov 2020 |
| Utility: DEUTERATED TETRAPEPTIDES THAT TARGET MITOCHONDRIA Filling date: 8 Sep 2025 Issue date: 19 Nov 2020 | 14 Nov 2018 | 19 Nov 2020 |
| Utility: Methods for treating Friedreich's ataxia by an aromatic-cationic peptide to increase frataxin protein levels Filling date: 8 Sep 2025 Issue date: 17 Nov 2020 | 29 May 2019 | 17 Nov 2020 |
| Utility: METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF BARTH SYNDROME Filling date: 8 Sep 2025 Issue date: 5 Nov 2020 | 15 Jul 2020 | 5 Nov 2020 |
| Utility: Methods for the treatment of mitochondrial diseases associated with a mutation in SURF 1 or POLG gene resulting in a disruption of mitochondrial oxidative phosphorylation Filling date: 8 Sep 2025 Issue date: 6 Oct 2020 | 28 Feb 2014 | 6 Oct 2020 |
| Utility: PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES Filling date: 8 Sep 2025 Issue date: 1 Oct 2020 | 9 Mar 2020 | 1 Oct 2020 |
| Utility: CRYSTALLINE DIPEPTIDES USEFUL IN THE SYNTHESIS OF ELAMIPRETIDE Filling date: 8 Sep 2025 Issue date: 10 Sep 2020 | 28 Mar 2019 | 10 Sep 2020 |
| Utility: Methods and compositions for the prevention and treatment of disease Filling date: 8 Sep 2025 Issue date: 18 Aug 2020 | 20 Aug 2015 | 18 Aug 2020 |
| Utility: AROMATIC-CATIONIC PEPTIDES AND METHODS FOR USING SAME Filling date: 8 Sep 2025 Issue date: 16 Jul 2020 | 20 Dec 2019 | 16 Jul 2020 |
| Utility: Combination therapies using cyclosporine and aromatic cationic peptides Filling date: 8 Sep 2025 Issue date: 7 Jul 2020 | 3 Jan 2017 | 7 Jul 2020 |
| Utility: Pharmaceutically relevant aromatic-cationic peptides Filling date: 8 Sep 2025 Issue date: 30 Jun 2020 | 28 Feb 2019 | 30 Jun 2020 |
| Utility: Crystalline salt forms Filling date: 8 Sep 2025 Issue date: 16 Jun 2020 | 10 Mar 2017 | 16 Jun 2020 |
| Utility: Crystalline bis- and tris-hydrochloride salt of elamipretide Filling date: 8 Sep 2025 Issue date: 9 Jun 2020 | 28 Jan 2019 | 9 Jun 2020 |
| Utility: NEUTRAL-CATIONIC PEPTOIDS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 21 May 2020 | 15 Nov 2019 | 21 May 2020 |
| Utility: Methods and compositions for the treatment of neuropathy and hyperalgesia Filling date: 8 Sep 2025 Issue date: 12 May 2020 | 22 Apr 2019 | 12 May 2020 |
| Utility: Processes for preparing pharmaceutically relevant peptides Filling date: 8 Sep 2025 Issue date: 28 Apr 2020 | 7 Mar 2016 | 28 Apr 2020 |
| Utility: Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening Filling date: 8 Sep 2025 Issue date: 21 Apr 2020 | 17 Jun 2015 | 21 Apr 2020 |
| Utility: METHODS AND COMPOSITIONS FOR REGULATING SRCA2A EXPRESSION LEVELS IN MYOCARDIAL INFARCTION Filling date: 8 Sep 2025 Issue date: 16 Apr 2020 | 11 Jun 2019 | 16 Apr 2020 |
| Utility: Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof Filling date: 8 Sep 2025 Issue date: 3 Mar 2020 | 27 May 2015 | 3 Mar 2020 |
| Utility: METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS Filling date: 8 Sep 2025 Issue date: 27 Feb 2020 | 25 Jan 2019 | 27 Feb 2020 |
| Utility: PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES Filling date: 8 Sep 2025 Issue date: 23 Jan 2020 | 28 Feb 2019 | 23 Jan 2020 |
| Utility: METHODS AND COMPOSITIONS FOR DETECTING AND DIAGNOSING DISEASES AND CONDITIONS Filling date: 8 Sep 2025 Issue date: 16 Jan 2020 | 10 Aug 2018 | 16 Jan 2020 |
